Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 20.00 |
P175131
Closed
Oraz Sultanov , Shuo Zhang
Ministry of Finance and Economy of Turkmenistan
December 24, 2020
(as of board presentation)
June 30, 2021
September 23, 2021
US$ 20.00 million
Ministry of Health and Medical Industry of Turkmenistan
2021
US$ 20.00 million
N/A
March 28, 2024
December 31, 2023
No
BANK APPROVED
Financier | Commitments |
---|---|
International Bank for Reconstruction and Development | 20.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | 20.00 |
IDA Commitment | N/A |
IBRD + IDA Commitment | 20.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 20.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
Jun 30, 2021 | IBRD-92850 | Loan Commitment | 20,000,000.00 |
Sep 23, 2021 | IBRD-92850 | Fee Charges | 50,000.00 |
Apr 15, 2024 | IBRD-92850 | Int Charges | 650,153.06 |
May 9, 2023 | IBRD-92850 | Loan Disb | 8,008,143.00 |
Oct 15, 2023 | IBRD-92850 | Int Charges | 10,295.05 |
Oct 15, 2023 | IBRD-92850 | Int Charges | 597,509.25 |
Apr 15, 2023 | IBRD-92850 | Int Charges | 443,754.50 |
Apr 15, 2023 | IBRD-92850 | Int Charges | 2,292.00 |
Apr 15, 2023 | IBRD-92850 | Int Charges | 15,346.92 |
May 9, 2023 | IBRD-92850 | Loan Disb | -8,008,143.00 |
Dec 21, 2022 | IBRD-92850 | Loan Disb | 4,994,519.00 |
Oct 15, 2022 | IBRD-92850 | Int Charges | 198,824.40 |
Oct 15, 2022 | IBRD-92850 | Int Charges | 6,260.25 |
Apr 15, 2022 | IBRD-92850 | Int Charges | 9,606.41 |
Apr 15, 2022 | IBRD-92850 | Int Charges | 49,099.99 |
Apr 15, 2022 | IBRD-92850 | Int Charges | 2,869.52 |
Apr 15, 2022 | IBRD-92850 | Int Charges | 23.84 |
Nov 17, 2021 | IBRD-92850 | Loan Disb | 14,955,481.00 |
Sep 23, 2021 | IBRD-92850 | Loan Disb | 50,000.00 |
Apr 15, 2024 | IBRD-92850 | Int Charges | 6,885.66 |
Name | Review | Date |
---|---|---|
Project Management | Satisfactory | 2024-04-17 |
Overall Implementation Progress (IP) | Highly Satisfactory | 2024-04-17 |
Procurement | Satisfactory | 2024-04-17 |
Progress towards achievement of PDO | Highly Satisfactory | 2024-04-17 |
Financial Management | Satisfactory | 2024-04-17 |
Monitoring and Evaluation | Satisfactory | 2024-04-17 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
PDO Indicator 3: Number of designated beds for COVID-19 patients with access to continuous oxygen supply | Value | 0.00 | 1000.00 | 600.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
PDO Indicator 1: Development and periodic update of a comprehensive national COVID-19 risk communication plan, including standardized, evidence-based information targeted to different population group | Value | No comprehensive national COVID-19 risk communicat | The comprehensive national COVID-19 risk communica | A comprehensive national COVID-19 risk communicati |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
PDO Indicator 2: Number of COVID-19 designated laboratories with verified diagnostic equipment and test kits. | Value | 0.00 | 18.00 | 5.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
PDO Indicator 4: A National Pandemic Preparedness and Response Plan is regularly updated and tailored for each region. | Value | A national Pandemic Preparedness and Response Plan | The National Pandemic Preparedness and Response Pl | The National Pandemic Preparedness and Response Pl |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of health staff (physicians and nurses) trained in infection prevention and control in accordance with approved protocols | Value | 0.00 | 4001.00 | 4000.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Clinical protocols, including a referral system, to care for COVID-19 patients are regularly reviewed or updated | Value | Clinical protocols, including a referral system, f | New Clinical protocols were approved. Seminars and | Clinical protocols, including a referral system, f |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Number of hospital and primary care physicians trained in the management of COVID-19 and SARI patients and adherence to COVID-19 protocols | Value | 0.00 | 2164.00 | 2000.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Number of COVID-19 designated laboratories with staff trained to conduct COVID-19 diagnosis | Value | 0.00 | 18.00 | 13.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
List of equipment, consumables and medications for resuscitation and management of COVID-19 and SARI patients with lung function disorders is defined and regularly updated. | Value | No verified list of equipment, consumables and med | A verified list of equipment, consumables and medi | A verified list of equipment, consumables and medi |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Electronic program for tracking and monitoring contacts developed and set up in Sanitary and Epidemiological Safety and Control (SESC) offices in Ashgabat and in five velayats | Value | No electronic program for tracking and monitoring | Installed and available on the state telecom compa | An electronic program for tracking and monitoring |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Number of focus groups conducted to engage communities, understand their needs and receive feedback on the project | Value | 0.00 | 16.00 | 16.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Number of risk communication messages targeted to different population groups developed | Value | 0.00 | 4.00 | 4.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Number of gender-specific information campaigns delivered. | Value | 0.00 | 2.00 | 2.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Percentage of participants in community meetings/events reporting that the local outreach and community engagement process is effective (disaggregated by gender) | Value | 0.00 | 75.00 | 75.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Number of public health specialists trained on climate-induced vector borne diseases and waterborne diseases | Value | 0.00 | 103.00 | 100.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Percentage increase in risk awareness of COVID-19 among PHC nurses | Value | 0.00 | 100.00 | 50.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |
Hospital preparedness plans on COVID-19 are prepared in 5 infectious disease hospitals in 5 districts and health workers trained | Value | 0.00 | 5.00 | 5.00 |
Date | January 29, 2021 | March 22, 2024 | December 31, 2023 | |
Comment |